Evidence map›Paper›PMID 12709095›Full record

ArticleJournal of general internal medicine2003

Usage patterns of over-the-counter phenazopyridine (pyridium).

Chih-Wen Shi, Steven M Asch, Eve Fielder, Lillian Gelberg, Robert H Brook, Barbara Leake, Martin F Shapiro, Patrick Dowling, Michael Nichol

Open access · bronzeAbstract read
In one paragraph

Article in Journal of general internal medicine, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
6.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Pharma's bad karma. Resistance is not futile.Journal of general internal medicine · 2003
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Chih-Wen ShiUniversity of California-Los Angeles, Departments of Family Medicine, Los Angeles, Calif. 90095, USA. cwshi@mednet.ucla.edu
Steven M Asch
Eve Fielder
Lillian Gelberg
Robert H Brook
Barbara Leake
Martin F Shapiro
Patrick Dowling
Michael Nichol
General Department of Preventive Medicine · VNRAND Corporation · USUniversity of California, Los Angeles · USUniversity of Southern California · USWest Los Angeles College · US

Funding

Usage Patterns of Over-the-Counter (OTC) PyridiumF32HS011507 · AHRQ · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SHI, CHIH-WEN · 2001 to 2001
–
AHRQ HHS F32 HS011507AHRQ HHS F32 HS 11507-01
6 · The paper itself

Abstract

objectivesLittle is known about how the public uses formerly prescription medications that are available over-the-counter (OTC). This study examines whether consumers inappropriately use and substitute a recently widely distributed OTC urinary analgesic, phenazopyridine, for provider care. DESIGN/

settingWe conducted a cross-sectional survey of a stratified cluster random sample of OTC phenazopyridine purchasers (N = 434) in 31 Los Angeles retail pharmacies over 5 months. Recruited by shelf advertisements, participants were 18 years or older who purchased a phenazopyridine product. Each completed a 25-item self-administered anonymous questionnaire. Inappropriate use was defined as 1) having medical contraindications to phenazopyridine, or 2) not having concurrent antibiotic and/or provider evaluation for the urinary symptoms.

resultsThe survey response rate was 58%. Fifty-one percent of the respondents used OTC phenazopyridine inappropriately, and 38% substituted it for medical care. Multiple logistic regression analyses revealed that inappropriate use was correlated with having little time to see a provider (odds ratio [OR], 1.57; 95% confidence interval [95% CI], 1.26 to 1.96), receiving friend's or family's advice (OR, 1.25; 95% CI, 1.05 to 1.47), having prior urinary tract infections (OR, 0.49; 95% CI, 0.30 to 0.80), having used prescription phenazopyridine, (OR, 0.40; 95% CI, 0.25 to 0.63), and having back pain (OR, 0.34; 95% CI, 0.16 to 0.74). Similar correlates were found in those who substituted OTC phenazopyridine for provider care. Respondents with incorrect knowledge about phenazopyridine's mode of action had 1.9 times greater odds of inappropriate use and 2.2 times greater odds of substitution than those who had correct knowledge about this drug.

conclusionInappropriate use of OTC phenazopyridine appears common. Increasing the public's knowledge about reclassified drugs may help to mitigate this problem.

Indexed as

Attitude to HealthSelf MedicationAdultAnesthetics, LocalConfidence IntervalsCross-Sectional StudiesFemaleHumansLogistic ModelsLos AngelesMaleNonprescription DrugsOdds RatioPhenazopyridineSocioeconomic FactorsSurveys and QuestionnairesAnesthetics, LocalNonprescription DrugsPhenazopyridine

Identifiers

PMID12709095
PMCPMC1494847
OpenAlexW2085271530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.